Abstract
Danggui Buxue Tang (DBT), an ancient Chinese herbal decoction commonly used to mitigate menopausal osteoporosis, contains two herbs: Astragali Radix (AR) and Angelicae Sinensis Radix (ASR). The exact efficacy of individual chemical(s) within DBT, or in any herbal mixture, is hard to be revealed. Calycosin and ferulic acid have been reported to be the predominant chemicals found within DBT, and its roles in regulating osteoblastic differentiation have been proposed here. To probe the roles of calycosin and ferulic acid, these chemicals were specifically depleted from the DBT extracts. Here, calycosin-depleted DBT (DBTΔcal) and ferulic acid-depleted DBT (DBTΔfa), generated by semi-preparative HPLC, were coupled with RNA-seq and metabolomics analyses to reveal the synergistic functions of individual chemicals within a complex herbal mixture. The expressions of osteogenic differentiation markers were significantly increased under the treatments of DBT and DBTΔfa. The DBT-induced genes were markedly reduced in the absent of calycosin, i.e., DBTΔcal. In cultured osteoblasts, the DBT-activated Wnt/β-catenin and MAPK/Erk and signaling pathways were greatly affected when calycosin was depleted. By metabolomics analysis in DBT-treated osteoblasts, the profile of metabolites triggered by DBTΔcal showed distinction to that of DBT and/or DBTΔfa. Thus, our findings indicated that calycosin, rather than ferulic acid, could be an indispensable chemical in DBT to orchestrate multi-components of DBT in achieving maximal osteogenic properties.
Highlights
Osteoporosis is one kind of bone diseases with reducing bone mineral density and elevated risk of fracture (Raisz, 2005)
The quality controls of Danggui Buxue Tang (DBT), DBT cal, and DBT fa were performed on a HPLC (Supplementary Figure S1A), as reported previously (Gong et al, 2015)
alkaline phosphatase (ALP) and Runx2 are the markers for earlier stage of differentiation, and the deposition of minerals is one of later indicative markers for osteoblastic differentiation (Lisberg et al, 2017)
Summary
Osteoporosis is one kind of bone diseases with reducing bone mineral density and elevated risk of fracture (Raisz, 2005). The reduced activity of osteoblastic differentiation is one of early symptoms of osteoporosis (Ota et al, 2016). This disease is one of the most common syndromes found within menopausal women. Estrogen replacement therapy (ERT) is widely utilized for mitigating. The side effects of ERT have been reported, i.e., possibly causing breast cancer and cardiovascular disease (Eden, 2013; Chuffa et al, 2017). Phytomedicine is a popular choice for women to reduce the menopausal symptoms. Traditional Chinese medicine (TCM) draws attention from the world because of its historical records of clinical efficacies and safety (Tan et al, 2016)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.